Riskpilot← Back to searchSign inGet full accessKILDA BIOLINK AS
ASActiveOrg 981954548Karenslyst Allé 10, 0278 OsloSupport activities for fishing and aquaculture · NACE 0330Est. 20000 employees
Revenue 2024
NOK 0
EBITDA margin
—
-17% vs 2023
Equity ratio
—
Financial strength
Net profit 2024
NOK -35K
-17% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -35K | -17% |
| Net profit | NOK -35K | -17% |
| Total assets | NOK 0 | — |
| Equity | NOK -5,3M | -1% |
| Employees | 0 | — |
Legal name
KILDA BIOLINK AS
Org number
981954548
Legal form
Aksjeselskap
NACE code
0330 · Support activities for fishing and aquaculture
Founded
5. mai 2000
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikle og markedsføre dermatologiske, kosmetiske og helseprodukter gjennom utnyttelse av ny teknologi og forskningsresultater. Dette skal skje ved egen forskning og ved samarbeidende institusjoner, både nasjonalt og internasjonalt.
Address
Karenslyst Allé 10, 0278 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 222 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −20 | 202 | −8 | −30 | −35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −20 | 202 | −8 | −30 | −35 |
| Net financials | 0 | 0 | 0 | −0 | 0 |
| Profit before tax | −20 | 202 | −8 | −30 | −35 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −20 | 202 | −8 | −30 | −35 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 0 | 222 | 0 | 0 | 0 |
| Equity | −5 396 | −5 194 | −5 202 | −5 233 | −5 268 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 396 | 5 416 | 5 202 | 5 233 | 5 268 |
| Total debt | 5 396 | 5 416 | 5 202 | 5 233 | 5 268 |
EBITDA margin
-3534400.0%
This company
15.8%
Market median
-22369720% vs market
20202024
Equity ratio
-526803100.0%
This company
38.2%
Market median
-1379065807% vs market
20202024
Return on equity
-3534400.0%
This company
18.4%
Market median
-19208796% vs market
20202024
Net profit margin
-3534400.0%
This company
8.1%
Market median
-43634668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TB Deputy Member | Deputy Member | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2025 | |
| Board of Directors | 2026 | |
| Chairman | 2025 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Chairman | 2016 – 2023 | |
| Chairman | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Varming Holding As
KILDA BIOLINK AS Board members of KILDA BIOLINK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tone Bjørnov | Deputy Member | 0 companies |
| Fredrik William Henriksen | Chairman | 0 companies |
| Roger Sebastian Sedal | Board of Directors | 0 companies |
| Kristian Flaten | Chairman | 0 companies |
| Edvard Cock | Chairman | 0 companies |
| Håvard Lindstrøm | Chairman | 0 companies |
| Jon Olav Ødegård | Board of Directors | 0 companies |